Pancreatic Irreversible Electroporation (IRE) Registry Study
This study collects information on a treatment for pancreatic cancer called Irreversible Electroporation (IRE). IRE is a way to treat tumors that cannot be removed by surgery. It uses electrical pulses to destroy cancer cells. This study helps doctors learn more about how well IRE works and any issues that might come up during treatment.
People 18 and older with pancreatic cancer may join if their doctor thinks IRE could help. You cannot join if you have a pacemaker, metal implants near the tumor, had a heart attack in the last 3 months, or cannot have general anesthesia (medicine to make you sleep during surgery).
- Study length is up to 2 years, with follow-ups every 3-6 months.
- No direct compensation, but you may help improve future cancer treatments.
- Risks include possible complications from treatment and the need for regular check-ups.
Your personal data will be kept private and only used for research with your permission. This can help doctors give better care to future patients with pancreatic cancer.